IMP3 and GLUT-1 Immunohistochemistry for Distinguishing Benign From Malignant Mesothelial Proliferations
- 1 March 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Surgical Pathology
- Vol. 37 (3), 421-426
- https://doi.org/10.1097/pas.0b013e31826ab1c0
Abstract
Distinguishing malignant mesotheliomas from benign mesothelial proliferations on hematoxylin and eosin-stained sections can be extremely challenging. Various immunohistochemical stains have been suggested to help in making this distinction, but all are controversial. Recently, IMP3 (insulin-like growth factor II mRNA binding protein 3) and GLUT-1 (glucose transporter protein 1) have been proposed as immunohistochemical markers that are positive in mesotheliomas but not in benign proliferations. We evaluated the performance of these markers on a tissue microarray containing 30 malignant mesotheliomas and 48 benign thoracic or abdominal mesothelial proliferations. IMP3 was positive in 53% of malignant and 27% of benign cases (P=0.03), whereas GLUT-1 was positive in 60% of malignant and 13% of benign cases (P=0.0003). Forty-three percent of malignant cases, but only 4% of benign cases, were positive for both IMP3 and GLUT-1 (P=0.00003). We conclude that, statistically, both IMP3 and GLUT-1 are more frequently positive in malignant compared with benign mesothelial processes; however, the frequency of positive staining in benign cases is too high to allow their diagnostic use as single stains. The combination of both markers may be of greater diagnostic value, but this hypothesis should be confirmed in further studies.Keywords
This publication has 26 references indexed in Scilit:
- CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesotheliomaDiagnostic Cytopathology, 2012
- Oncofetal Protein IMP3, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma From Reactive Mesothelial ProliferationThe American Journal of Surgical Pathology, 2011
- Immunohistochemical Detection of XIAP in Mesothelium and Mesothelial LesionsAmerican Journal of Clinical Pathology, 2007
- Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesotheliomaLaboratory Investigation, 2007
- Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reportsHistopathology, 2006
- Immunocytochemical detection of XIAP in body cavity effusions and washesLaboratory Investigation, 2005
- The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet‐derived growth factor‐receptor, P‐glycoprotein and Bcl‐2Histopathology, 2003
- The Separation of Benign and Malignant Mesothelial ProliferationsThe American Journal of Surgical Pathology, 2000
- The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesotheliosesCancer, 1998
- Immunoreactivity for p53 protein in malignant mesothelioma and non‐neoplastic mesotheliumThe Journal of Pathology, 1992